Stem cell technology recreating human intestinal epithelium
Altis Biosystems, Inc. is a preclinical contract research organization whose patent-pending stem cell platform recreates the human intestinal epithelium in a high-throughput format for drug screening and microbiome research. Altis provides a variety of services for customers, including toxicology, permeability, ELISA, transport, custom cell isolation, and more. In addition to providing services utilizing its platform, Altis is able to ship its platform to customers as well.